DK0471794T3 - Antiviral terapi ved anvendelse af thiazin- og xanthenfarvestoffer - Google Patents

Antiviral terapi ved anvendelse af thiazin- og xanthenfarvestoffer

Info

Publication number
DK0471794T3
DK0471794T3 DK90909103.5T DK90909103T DK0471794T3 DK 0471794 T3 DK0471794 T3 DK 0471794T3 DK 90909103 T DK90909103 T DK 90909103T DK 0471794 T3 DK0471794 T3 DK 0471794T3
Authority
DK
Denmark
Prior art keywords
thiazine
dyes
xanthene dyes
antiviral therapy
dye
Prior art date
Application number
DK90909103.5T
Other languages
English (en)
Inventor
Raymond F Schinazi
Robert A Floyd
Original Assignee
Oklahoma Med Res Found
Raymond F Schinazi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26996594&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0471794(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Oklahoma Med Res Found, Raymond F Schinazi filed Critical Oklahoma Med Res Found
Application granted granted Critical
Publication of DK0471794T3 publication Critical patent/DK0471794T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
    • A61M1/3683—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation using photoactive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Pyrane Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK90909103.5T 1989-05-11 1990-05-11 Antiviral terapi ved anvendelse af thiazin- og xanthenfarvestoffer DK0471794T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35038389A 1989-05-11 1989-05-11
US38900789A 1989-08-03 1989-08-03

Publications (1)

Publication Number Publication Date
DK0471794T3 true DK0471794T3 (da) 1996-11-18

Family

ID=26996594

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90909103.5T DK0471794T3 (da) 1989-05-11 1990-05-11 Antiviral terapi ved anvendelse af thiazin- og xanthenfarvestoffer

Country Status (8)

Country Link
EP (1) EP0471794B1 (da)
JP (2) JPH07119173B2 (da)
AT (1) ATE143596T1 (da)
CA (1) CA2055463C (da)
DE (2) DE471794T1 (da)
DK (1) DK0471794T3 (da)
ES (1) ES2032742T3 (da)
WO (1) WO1990013296A1 (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6090043A (ja) * 1983-10-21 1985-05-21 Nippon Shokubai Kagaku Kogyo Co Ltd 窒素酸化物浄化用触媒
DE3930510A1 (de) * 1989-09-13 1991-03-21 Blutspendedienst Dt Rote Kreuz Verfahren zur inaktivierung von viren in blut und blutprodukten
US5545516A (en) * 1990-05-01 1996-08-13 The American National Red Cross Inactivation of extracellular enveloped viruses in blood and blood components by phenthiazin-5-ium dyes plus light
WO1991016911A1 (en) * 1990-05-01 1991-11-14 The American National Red Cross Decontamination of whole blood and cellular components by phenthiazin-5-ium-dyes plus light
US6207107B1 (en) 1992-10-05 2001-03-27 Baxter International Inc. Steam sterilizable system for inactivating viral contaminants in body fluids
US5660731A (en) * 1994-11-08 1997-08-26 Pall Corporation Filter for separating photoactive agent
AT406778B (de) * 1996-04-09 2000-09-25 Immuno Ag Verfahren zur desintegration von nucleinsäuren und herstellung von qualitätsgesicherten biologischen produkten
US5935581A (en) * 1996-07-24 1999-08-10 Kapadia; Govind J. Inhibitory effects of synthetic and natural colorants on carcinogenesis
US8974363B2 (en) 1997-12-11 2015-03-10 Provectus Pharmatech, Inc. Topical medicaments and methods for photodynamic treatment of disease
US6248733B1 (en) 1998-01-09 2001-06-19 3M Innovative Properties Company Method for limiting the growth of microorganisms using metal-containing compounds
US8557298B2 (en) 1998-08-06 2013-10-15 Provectus Pharmatech, Inc. Medicaments for chemotherapeutic treatment of disease
US6610436B1 (en) 1998-09-11 2003-08-26 Gore Enterprise Holdings Catalytic coatings and fuel cell electrodes and membrane electrode assemblies made therefrom
JP5689573B2 (ja) 1999-08-13 2015-03-25 プロヴェクタス ファーマテック，インク． 疾患の光線力学的療法のための改良された局所用薬品および方法
US6432396B1 (en) 2000-07-06 2002-08-13 3M Innovative Properties Company Limiting the presence of microorganisms using polymer-bound metal-containing compositions
JP2007512297A (ja) * 2003-11-28 2007-05-17 フォトファーマイカ リミテッド 生物活性メチレンブルー誘導体（２）における開発
SG135190A1 (en) * 2004-02-20 2007-09-28 Robert F Hofmann Use of targeted oxidative therapeutic formulation in treatment of viral diseases
WO2006032879A2 (en) * 2004-09-23 2006-03-30 Wista Laboratories Ltd. Methods of chemical synthesis and purification of diaminophenothiazinium compounds including methylthioninium chloride (mtc)
CN101084204B (zh) * 2004-09-23 2012-12-05 卫思道制药有限公司 包括亚甲蓝(mtc)在内的二氨基吩噻嗪鎓化合物的化学合成和纯化方法
US20060188866A1 (en) * 2005-02-18 2006-08-24 Children's Hospital Oakland Research Institute Diaminophenothiazine compositions and uses thereof
FR2899088B1 (fr) * 2006-03-31 2008-06-27 Mauna Kea Technologies Soc Par "microscopie de fluorescence fibree a base de bleu de methylene."
CN102958525B (zh) 2010-04-30 2017-05-24 普罗瑟塔抗病毒股份有限公司 抗病毒化合物
EP2699241B1 (en) 2011-04-20 2016-07-27 Prosetta Antiviral Inc. Antiviral compounds
US11938182B2 (en) 2020-03-26 2024-03-26 Provectus Pharmatech, Inc. Halogenated xanthenes as vaccine adjuvants
JP7512409B6 (ja) * 2020-03-26 2024-07-23 プロヴェクタス ファーマテック，インク． 腫瘍学及びウイルス学におけるハロゲン化キサンテンの新規の使用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA993795A (en) * 1970-12-10 1976-07-27 Richardson-Merrell (Canada) Ltd. Antiviral compositions containing bis-basic ethers and thioethers of xanthene and xanthen-9-ones and methods of treating viruses therewith
US4305390A (en) * 1975-11-28 1981-12-15 Massachusetts Institute Of Technology Method for generating oxygen in an excited electronic state and inactivation of microorganisms
DE3341001A1 (de) * 1983-11-12 1985-05-23 Krause, Hans Jürgen Nanopartikel aus bioabbaubarem, synthetischem material, verfahren zu deren herstellung und ihre anwendung

Also Published As

Publication number Publication date
JPH08151327A (ja) 1996-06-11
DE471794T1 (de) 1992-07-23
EP0471794A1 (en) 1992-02-26
DE69028775D1 (de) 1996-11-07
JPH04507403A (ja) 1992-12-24
DE69028775T2 (de) 1997-05-07
EP0471794A4 (en) 1992-05-06
ATE143596T1 (de) 1996-10-15
WO1990013296A1 (en) 1990-11-15
EP0471794B1 (en) 1996-10-02
CA2055463C (en) 1997-09-30
ES2032742T3 (es) 1997-02-01
JP2700126B2 (ja) 1998-01-19
CA2055463A1 (en) 1990-11-12
JPH07119173B2 (ja) 1995-12-20
ES2032742T1 (es) 1993-03-01

Similar Documents

Publication Publication Date Title
DK0471794T3 (da) Antiviral terapi ved anvendelse af thiazin- og xanthenfarvestoffer
DK0745852T3 (da) Anvendelse af funktionelle derivater af intercellulær adhæsion-molekylet ICAM-1 i antiviral terapi
BR8705535A (pt) Polipeptideos derivados do gene de tegumento de virus de imunodeficiencia humana em celulas de insetos infectados por baculovirus
ES8705764A1 (es) Procedimiento fotodinamico de inactivacion de virus
ES2131116T3 (es) Analogos de nucleotidos enantiomericos antirretrovirales.
PT89838A (pt) Processo para a preparacao de agente terapeutico susceptivel de formar um complexo com glicoproteina de involucro de virus de imunodeficiencia humana
DK0459779T3 (da) Immunoreagenser der reagerer med en konserveret epitop af human immundefekt virus type I (HIV-1) gp120 samt fremgangsmåder til anvendelse deraf
ES2123048T3 (es) Analogos de nucleosidos antiviricos.
DE3773892D1 (de) Medizinische verwendung von nukleosiden.
DK0491764T3 (da) Benzophenonether-estere, fremgangsmåde til deres fremstilling og deres anvendelse til forbedring af polyesterfarvningers lysstabilitet
DE68923035D1 (de) Nachweis von Lanthanid-markierte Nukleotide mittels zeitgelöster Fluorometrie.
DK198387D0 (da) 1-hydroxy-2-pyridoner, deres fremstilling og anvendelse samt ved fremgangsmaaden anvendelige mellemprodukter og disses fremstilling
DK155714C (da) Fremgangsmaade til fremstilling af en steril, injicerbar, fysiologisk acceptabel oploesning af et roentgenkontrastmiddel, samt en oploesning af roentgenkontrastmidlet til brug ved fremgangsmaaden
DK430989D0 (da) Transdermalt anvendeligt laegemiddel med et indhold af farmaceutisk anvendelige glykosider
DK442987A (da) 1-aryl-3-tert.butyl-pyrazoler, fremgangsmaader til deres fremstilling samt deres anvendelse til bekaempelse af skadelige organismer
DK90090A (da) Fremgangsmaade til fremstilling af naturligt hiv gp160
ATE59778T1 (de) Verwendung von sulfonamidderivaten zur herstellung eines antivirusmittels.
DK335987A (da) Dna-sekvens, rekombinerede dna-molekyler og fremgangsmaade til fremstilling af newcastle disease virus fussionsprotein eller aekvivalente polypeptider ved fremgangsmaaden opnaaede produkter samt praeparater der indeholder dem
DK135588D0 (da) Inaktivering af hiv i proteinholdige oploesninger ved hjaelp af phenoler
DK31389D0 (da) Beholdersystem til indsamling af brugte kanyler, sproejter og andre brugte engangsartikler eller andet risikobetonet eller smittefarligt affald
SU782756A1 (ru) Рабочий орган дл фрезеровани пней
DK14288A (da) Halogenalkyl-, alkenyl- og alkynylazoler, fremgangsmaader til deres fremstilling samt deres anvendelse til bekaempelse af skadelige organismer
DK365489D0 (da) Fremgangsmaade til diagnostisering af hiv-infektion og diagnostiseringsapparat til anvendelse ved fremgangsmaaden
DK675887D0 (da) Aminomethyloxazolidiner, fremgangsmaader til deres fremstilling samt deres anvendelse til bekaempelse af skadelige organismer
RU98109354A (ru) Способ подавления репродукции вируса иммунодефицита человека